Abstract No. 163 Transarterial Radioembolization Versus Transarterial Chemoembolization Plus Percutaneous Ablation for Unresectable, Solitary Hepatocellular Carcinoma ≥3 Cm: a Propensity Score Matched Study

Q. Yu, N. Thapa, K. Karani,O. Ahmed,R. Navuluri,T. Van Ha

Journal of vascular and interventional radiology（2022）

引用 0|浏览3

暂无评分

摘要

To compare safety and efficacy of transcatheter arterial chemoembolization (TACE) with drug-eluting embolic agents combined with percutaneous ablation versus radioembolization (TARE) in treatment of treatment-naïve solitary unresectable hepatocellular carcinoma (HCC) ≥3cm

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要